The preclinical facilities at Sydney Imaging provide a wide range of modality options for healthcare researchers conducting in vivo studies for clinical translation.
Provides superior soft tissue contrast and molecular imaging capability. Pulse sequences include high-resolution anatomical imaging, fMRI, diffusion MRI, angiography spectroscopy, amoung many others. Sydney Imaging has two different preclinical MRI sacnners from MR Solutions, a 3 Tesla (MRS 3017) and 7 Tesla (MRS 7024).
|
3T (MRS 3017) |
7T (MRS 7024) |
Field strength |
0.1T – 3.0T (rampable) |
0.1T – 7.0T (rampable) |
Bore size |
17cm |
24cm |
F.O.V |
Elliptical: 100mm x 70mm |
Elliptical: 154mm x 98mm |
Homogeneity |
Over 30mm +/- 0.1ppm, |
Over 42mm DSV +/- 0.1ppm, Over 84mm DSV +/- 1ppm |
Gradient strength |
X – 486 mT/m |
X – 344 mT/m Y – 332 mT/m Z – 375 mT/m |
Rx/Tx channels |
2 to 16 / 1 or 2 |
4 to 16 / 2 |
The EchoMRI 900 is a high-throughput body composition analyser that employs magnetic resonance relaxation analysis for measuring fat tissue, lean tissue, free water and total water masses in alert models, weighing up to 900g. The system is easy to operate and ideal for longitudinal body composition measurements. Applications include obesity and nutrition studies.
Positron Emission Tomography (PET) imaging is a powerful molecular imaging modality, which produces spatiotemporal quantitative 3D and 4D (3D+time) images of several physiological processes in vivo, such as metabolic activity and receptor occupancy/density. When combined with computed tomography (CT) or magnetic resonance imaging (MRI), high-sensitivity functional information of metabolic or biochemical activity can be superimposed (co-registered) with high-resolution structural images, adding precision of anatomical localisation to functional processes.
We are currently also establishing a radiochemistry facility at Sydney Imaging, to support radiotracer development.
Sydney Imaging users can access state-of-the-art imaging facilities and methodological expertise on experimental design, data acquisition and image processing. Available emission tomography imaging equipment includes:
Modality/Scanner | Field of view (transaxial/axial) | Spatial resolution | Absolute sensitivity |
---|---|---|---|
PET MicroPET Focus220 (Siemens) |
190mm/76mm | 1.7mm (centre of FOV) | 3.4% |
3T PET/MR I-402 PET insert (MR Solutions) |
40mm/98mm | 1.5mm (centre of FOV) | 10.15% |
PET/CT Si78 (Bruker) |
80mm/200mm | 0.7mm (centre of FOV) | 12.0% |
DXA is a non-invasive technique which uses small dose of ionizing radiation to image bone density and body composition. The InAlyzer DXA system provides accurate and precise measurements of bone mineral density, bone, fat and lean contents in rodents within a short imaging time. Applications include diet, genetics, cell physiology, materials research studies and more.
Key features
Specifications
X-ray Energy in DXA mode |
55 kV (low) and 80 kV (high) |
Imaging Mode |
DR and DXA |
Beam Type |
Fan Beam |
Scan Time |
1 - 5 min (DXA) |
Scan Area (mm) |
140 ´ 210 mm |
Detector Resolution |
108 mm |
Sydney Imaging has two systems, one at the Charles Perkins Centre and the other at Kolling Institute. These include the Vevo F2 LAZR-X Multi-Modal Imaging system, which is the most advance hybrid micro-imaging system providing inherent co-registration of the photoacoustic signal with anatomical ultrasound imaging, providing anatomical, physiological, functional and molecular data. Applications include cardiology, vascular biology, oncology, developmental biology, neurology, biomarker/molecular imaging, tissue perfusion and contrast imaging.
Frequency range |
13 – 70 MHz |
Frame rate |
Up to 1000 fps |
Spatial resolution |
Up to 30 µm |
Transducers |
3 available linear array transducers: MS700 – 30 – 70 MHz MS550D – 22 – 55 MHz LZ250 – 13 – 24 MHz (with photoacoustic capability) |
VevoLAZR-X |
680 – 970 nm wavelength , 1cm tissue penetration, 75 µm resolution |
The IVIS Spectrum CT is a multimodality imaging instrument capable of optical imaging (bioluminescence, fluorescence) and low dose CT for anatomical registration in small anaesthetised animals as well as ex vivo and in vitro samples. This technology offers longitudinal in vivo monitoring of disease progression, drug treatments and biomarker development. Applications include oncology, musculo-skeletal, cardiovascular, neurology, infectious diseases and respiratory research.
Max. field of view |
23 x 23cm |
Pixel size/Resolution |
13.5 µm/29 µm |
10 Narrow band excitation filters |
415 nm -760 nm (30 nm bandwidth) |
18 narrow band emission filters |
490 nm -850 nm (20 nm bandwidth) |
Magnifications |
1.5x, 2.5x, 5x, 8.7x |
Field of view |
120 x120 x 30 (L X W X H, mm) to 20 X 2 X 20 (L X W X H, mm) |
Voxel size |
40 µm – 300 µm |
Reconstruction time |
40 – 150 sec |
Limiting resolution |
150 µm |
Standard scan time |
3.6 to 72 sarc |
Standard scan dose |
minimum of ~13 mGy |
Micro-computed tomography (Micro-CT) is capable of generating 3D images of internal microstructure and morphology in living animals or materials (bones, soft tissues, composites) with high resolution. Our MiLab MicroCT scanner offers non-destructive slice-by-slice scanning that can be reconstructed into 3D volumetric objects for quantitative analysis or visualisation. Applications include oncology, bone morphometry, cardiovascular research, respiratory studies, contrast agent development and materials science.
Sydney Imaging offers radiochemistry capabilities at the Brain and Mind Centre. Our lab is equipped with two hot cells, a radiation fume hood, radio-HPLC analysis, a gamma counter, and the Flexlab synthesis module, enabling sophisticated radiolabelling of various molecules and peptides with 18F. For smaller-scale projects, we also offer manual radiolabelling. A key feature of our facility is the 68Ga generator, which provides a consistent and substantial source of activity, ensuring efficient and timely radiolabelling and research. Our capabilities extend to in-vitro studies, allowing for the evaluation of newly developed compounds on cells prior to animal studies, thus bridging the gap between pre-clinical research and clinical application. We currently work with 18F, 64Cu, 68Ga, and 11C isotopes.